XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 103,063 $ 1,219,233
Adjustments to reconcile net income to net cash provided by operating activities:    
Deferred income tax expense 23,394 356,618
Depreciation and depletion 486,750 387,685
Impairments and loss/gain on sale/exchange of long-lived assets 9,356 27,074
Income from investments (2,260) (4,764)
Loss (gain) on debt extinguishment 3,449 (6,606)
Share-based compensation expense 10,551 11,276
Distribution of earnings from equity method investment 2,852 5,456
Amortization, accretion and other 2,797 3,888
Gain on derivatives (106,511) (824,852)
Net cash settlements received on derivatives 451,004 157,000
Net premiums paid on derivatives (33,904) (94,916)
Changes in other assets and liabilities:    
Accounts receivable 372,654 980,908
Accounts payable (117,157) (422,519)
Other current assets (55,501) (80,472)
Other items, net 5,126 (52,241)
Net cash provided by operating activities 1,155,663 1,662,768
Cash flows from investing activities:    
Capital expenditures (534,468) (494,784)
Cash paid for acquisitions (30,053) 0
Other investing activities (2,631) (3,542)
Net cash used in investing activities (567,152) (498,326)
Cash flows from financing activities:    
Proceeds from revolving credit facility borrowings 107,000 0
Repayment of revolving credit facility borrowings (107,000) 0
Proceeds from issuance of debt 750,000 0
Proceeds from net settlement of capped call transactions 93,290 0
Debt issuance costs (8,147) 0
Repayment and retirement of debt (752,112) (211,429)
Discounts received on debt extinguishment 0 7,981
Dividends paid (69,412) (54,070)
Repurchase and retirement of common stock 0 (201,029)
Net distribution to noncontrolling interest 0 (85)
Other financing activities (35,059) (37,192)
Net cash used in financing activities (21,440) (495,824)
Net change in cash and cash equivalents 567,071 668,618
Cash and cash equivalents at beginning of period 80,977 1,458,644
Cash and cash equivalents at end of period $ 648,048 $ 2,127,262